The Princess Margaret Cancer Centre, previously called Princess Margaret Hospital, is a scientific research centre and a teaching hospital in Toronto, Ontario, Canada, affiliated with the University of Toronto Faculty of Medicine as part of the University Health Network.

During the past decade, University Health Network - Oci / Princess Margaret Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Health Network - Oci / Princess Margaret Hospital" #1 collaborator was "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Canadian Urologic Oncology Group" with 1 trials as a collaborator, "Celgene" with 1 trials as a collaborator, "Cooperative Trials Group for Neuro-Oncology" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "University Health Network - Oci / Princess Margaret Hospital" are "Brain and Central Nervous System Tumors" (1 trials), "Kidney Cancer" (1 trials) and "Newly Diagnosed Glioblastoma" (1 trials). Many other conditions were trialed in "University Health Network - Oci / Princess Margaret Hospital" in a lesser frequency.

Most popular intervention types in "University Health Network - Oci / Princess Margaret Hospital" are "Drug" (2 trials), "Genetic" (2 trials), "Other" (2 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "laboratory biomarker analysis" (2 trials), "DNA methylation analysis" (1 trials), "Marizomib" (1 trials), "Temozolomide" (1 trials) and "adjuvant therapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Health Network - Oci / Princess Margaret Hospital" are 3 trials for "All" genders.

Currently, there are NaN active trials in "University Health Network - Oci / Princess Margaret Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in University Health Network - Oci / Princess Margaret Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University Health Network - Oci / Princess Margaret Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".